MENU
ORYZF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Oryzon Genomics SA (ORYZF) Ownership - Who owns Oryzon Genomics SA?

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics... Show more

Profile

Industry
N/A
Address
Sant Ferran 74
Phone
+34 935151313
Employees
40
Web
http://www.oryzon.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
238.91M
P/E Ratio
N/A
Total Cash
31.11M
Projected Growth
N/A
Total Debt
13.73M
Revenue
N/A
Risk (Beta)
-0.54
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ORYZF
Capitalization
239M
P/E Ratio
N/A
Risk (Beta)
-0.54
Dividend Yield
N/A
Total Cash
31.1M
Total Cash/Share
0.40
Total Debt
13.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
114M
P/B Ratio
1.91
Cash Flow
N/A
Earnings
-0.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.93M
Current Ratio
2.62
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-4.35M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-3.39
Shares Held By Institutions
1.22M
Shares Outstanding - Current
77.5M
Total Liabilities
24.1M
Total Volume MTD
N/A
Value
1
Gain YTD
102.469
View a ticker or compare two or three
ORYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Sant Ferran 74
Phone
+34 935151313
Employees
40
Web
http://www.oryzon.com